Challenges in translating vascular tissue engineering to the pediatric clinic

Vascular Cell

Volumn 3, Issue , 2011, Pages

  Duncan, Daniel R ^a   Breuer, Christopher K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

congenital heart disease; Tissue engineered vascular grafts; translational research

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANGIOGENESIS; BLOOD VESSEL GRAFT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL VIABILITY; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONGENITAL HEART MALFORMATION; GRAFT FAILURE; GRAFT PATENCY; HEART SURGERY; HUMAN; MONONUCLEAR CELL; NONHUMAN; PATIENT SAFETY; PEDIATRIC SURGERY; PRIORITY JOURNAL; REVIEW; STENOSIS; SURGICAL TECHNIQUE; TISSUE ENGINEERING; TREATMENT OUTCOME; VASCULAR TISSUE;

ANIMALIA; MURINAE;

EID: 84858057923     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-3-23     Document Type: Review

References (51)

1. Technology insight: the evolution of tissue-engineered vascular grafts - from research to clinical practice. L'Heureux N, Dusserre N, Marini A, Garrido S, de la Fuente L, McAllister T, Nat Clin Pract Cardiovasc Med 2007 4 7 389 395 10.1038/ncpcardio0930 17589429 (Pubitemid 47023444)
2. Tissue engineering. Langer R, Vacanti JP, Science 1993 260 5110 920 926 10.1126/science.8493529 8493529 (Pubitemid 23209960)
3. Creation of viable pulmonary artery autografts through tissue engineering. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE Jr, J Thorac Cardiovasc Surg 1998 115 3 536 545 discussion 545-536 10.1016/S0022-5223(98)70315-0 9535439 (Pubitemid 28158068)
4. Successful application of tissue engineered vascular autografts: clinical experience. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T, Biomaterials 2003 24 13 2303 2308 10.1016/S0142-9612(03)00043-7 12699667 (Pubitemid 36434049)
5. Evaluation of tissue-engineered vascular autografts. Matsumura G, Ishihara Y, Miyagawa-Tomita S, Ikada Y, Matsuda S, Kurosawa H, Shin'oka T, Tissue Eng 2006 12 11 3075 3083 10.1089/ten.2006.12.3075 17518623 (Pubitemid 44846413)
6. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Watanabe M, Shin'oka T, Tohyama S, Hibino N, Konuma T, Matsumura G, Kosaka Y, Ishida T, Imai Y, Yamakawa M, et al. Tissue Eng 2001 7 4 429 439 10.1089/10763270152436481 11506732 (Pubitemid 32734775)
7. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, et al. Lancet 2009 373 9673 1440 1446 10.1016/S0140-6736(09)60248-8 19394535
8. Properties of the human umbilical vein as a living scaffold for a tissue-engineered vessel graft. Hoenicka M, Lehle K, Jacobs VR, Schmid FX, Birnbaum DE, Tissue Eng 2007 13 1 219 229 10.1089/ten.2006.0121 17518595 (Pubitemid 46175543)
9. In vivo engineering of blood vessels. Daly CD, Campbell GR, Walker PJ, Campbell JH, Front Biosci 2004 9 1915 1924 10.2741/1384 14977597 (Pubitemid 38918641)
10. Development of novel biodegradable polymer scaffolds for vascular tissue engineering. Gui L, Zhao L, Spencer RW, Burghouwt A, Taylor MS, Shalaby SW, Niklason LE, Tissue Eng Part A 2011 17 9-10 1191 1200 10.1089/ten.tea.2010.0508 21143045
11. Vascular tissue engineering: Towards the next generation vascular grafts. Naito Y, Shinoka T, Duncan D, Hibino N, Solomon D, Cleary M, Rathore A, Fein C, Church S, Breuer C, Adv Drug Deliv Rev 2011 63 4-5 312 323 10.1016/j.addr.2011. 03.001 21421015
12. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. He W, Yong T, Teo WE, Ma Z, Ramakrishna S, Tissue Eng 2005 11 9-10 1574 1588 10.1089/ten.2005.11.1574 16259611 (Pubitemid 41636442)
13. Decellularized tissue-engineered blood vessel as an arterial conduit. Quint C, Kondo Y, Manson RJ, Lawson JH, Dardik A, Niklason LE, Proc Natl Acad Sci USA 2011 108 22 9214 9219 10.1073/pnas.1019506108 21571635
14. Tissue engineering on matrix: future of autologous tissue replacement. Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP, Semin Immunopathol 2011 33 3 307 315 10.1007/s00281-011-0258-8 21279358
15. Readily available tissue-engineered vascular grafts. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, et al. Sci Transl Med 2011 3 68 68ra69
16. Comparison of Human Bone Marrow Mononuclear Cell Isolation Methods for Creating Tissue Engineered Vascular Grafts: Novel Filter System versus Traditional Density Centrifugation Method. Hibino N, Nalbandian A, Devine L, Martinez RS, McGillicuddy EA, Yi T, Karandish S, Ortolano GA, Shinoka T, Snyder E, et al. Tissue Eng Part C Methods 2011 17 10 993 8 10.1089/ten.tec.2011.0110 21609305
17. Therapeutic potential of embryonic stem cells. Lerou PH, Daley GQ, Blood Rev 2005 19 6 321 331 10.1016/j.blre.2005.01.005 16275420 (Pubitemid 41571932)
18. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 5 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
19. Embryonic stem cell lines derived from human blastocysts. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM, Science 1998 282 5391 1145 1147 9804556 (Pubitemid 28516247)
20. Evaluation of the use of an iPS cell sheet for creating tissue engineered vascular grafts. Hibino N, Duncan DR, Nalbandian A, Yi T, Qyang Y, Shinoka T, Breuer CK, The Journal of Thoracic and Cardiovascular Surgery 2011
21. Cell-seeding techniques in vascular tissue engineering. Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, Painter C, Mirensky T, Erickson B, Shinoka T, et al. Tissue Eng Part B Rev 2010 16 3 341 350 10.1089/ten.teb.2009.0527 20085439
22. Development of an Operator-Independent Method for Seeding Tissue-Engineered Vascular Grafts. Udelsman B, Hibino N, Villalona GA, McGillicuddy E, Nieponice A, Sakamoto Y, Matsuda S, Vorp DA, Shinoka T, Breuer CK, Tissue Eng Part C Methods 2011 17 7 731 6 10.1089/ten.tec.2010.0581 21410308
23. Tissue-engineered blood vessels in pediatric cardiac surgery. Shinoka T, Breuer C, Yale J Biol Med 2008 81 4 161 166 19099046
24. The development and translation of the tissue-engineered vascular graft. Breuer CK, J Pediatr Surg 2011 46 1 8 17 10.1016/j.jpedsurg.2010.09.058 21238633
25. American Heart Association 2008 Annual Report.
26. Children with congenital heart disease: probability of natural survival. Samanek M, Pediatr Cardiol 1992 13 3 152 158 1603715
27. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. Giannico S, Hammad F, Amodeo A, Michielon G, Drago F, Turchetta A, Di Donato R, Sanders SP, J Am Coll Cardiol 2006 47 10 2065 2073 10.1016/j.jacc.2005.12.065 16697327
28. The extracardiac conduit Fontan operation using minimal approach extracorporeal circulation: early and midterm outcomes. Petrossian E, Reddy VM, Collins KK, Culbertson CB, MacDonald MJ, Lamberti JJ, Reinhartz O, Mainwaring RD, Francis PD, Malhotra SP, et al. J Thorac Cardiovasc Surg 2006 132 5 1054 1063 10.1016/j.jtcvs.2006.05.066 17059923 (Pubitemid 44584961)
29. Commentary on: Petrossian E, Reddy VM, McElhinney DB, Akkersdiuk GP, Moore P, Parry AJ, Thompson LD, Hanley FL. Early results of extracardiac conduit Fontan operation. Jonas R, J Thorac Cardiovasc Surg 1999 117 688 696 10.1016/S0022-5223(99)70288-6 10096963
30. Outcome after a "perfect" Fontan operation. Fontan F, Kirklin JW, Fernandez G, Costa F, Naftel DC, Tritto F, Blackstone EH, Circulation 1990 81 5 1520 1536 10.1161/01.CIR.81.5.1520 2331765
31. The incidence of congenital heart disease. Hoffman JI, Kaplan S, J Am Coll Cardiol 2002 39 12 1890 1900 10.1016/S0735-1097(02)01886-7 12084585 (Pubitemid 34628268)
32. The ideal small arterial substitute: a search for the Holy Grail? Conte MS, FASEB J 1998 12 1 43 45 9438409
33. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. Kakisis JD, Liapis CD, Breuer C, Sumpio BE, J Vasc Surg 2005 41 2 349 354 10.1016/j.jvs.2004.12.026 15768021 (Pubitemid 40342491)
34. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Dearani JA, Danielson GK, Puga FJ, Schaff HV, Warnes CW, Driscoll DJ, Schleck CD, Ilstrup DM, Ann Thorac Surg 2003 75 2 399 410 discussion 410-391 10.1016/S0003-4975(02)04547-2 12607647 (Pubitemid 36184480)
35. Early results of the extracardiac conduit Fontan operation. Petrossian E, Reddy VM, McElhinney DB, Akkersdijk GP, Moore P, Parry AJ, Thompson LD, Hanley FL, J Thorac Cardiovasc Surg 1999 117 4 688 696 10.1016/S0022-5223(99)70288-6 10096963 (Pubitemid 29163072)
36. The use of valved conduits in pediatric cardiac surgery. Stark J, Pediatr Cardiol 1998 19 4 282 288 10.1007/s002469900311 9636251 (Pubitemid 28290042)
37. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Homann M, Haehnel JC, Mendler N, Paek SU, Holper K, Meisner H, Lange R, Eur J Cardiothorac Surg 2000 17 6 624 630 10.1016/S1010-7940(00)00414-0 10856850 (Pubitemid 30364936)
38. Late results of the peel operation for replacement of failing extracardiac conduits. Bermudez CA, Dearani JA, Puga FJ, Schaff HV, Warnes CA, O'Leary PW, Schleck CD, Danielson GK, Ann Thorac Surg 2004 77 3 881 887 discussion 888 10.1016/j.athoracsur.2003.08.029 14992892 (Pubitemid 38271054)
39. Long-term follow-up of patients with synthetic right heart conduits. Jonas RA, Freed MD, Mayer JE Jr, Castaneda AR, Circulation 1985 72 3 Pt 2 I77 83 3161661
40. Late-term results of tissue-engineered vascular grafts in humans. Hibino N, McGillicuddy E, Matsumura G, Ichihara Y, Naito Y, Breuer C, Shinoka T, J Thorac Cardiovasc Surg 2010 139 2 431 436 436 e431-432 10.1016/j.jtcvs.2009.09. 057 20106404
41. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. Naito Y, Imai Y, Shin'oka T, Kashiwagi J, Aoki M, Watanabe M, Matsumura G, Kosaka Y, Konuma T, Hibino N, et al. J Thorac Cardiovasc Surg 2003 125 2 419 420 10.1067/mtc.2003.134 12579118 (Pubitemid 36228326)
42. Transplantation of a tissue-engineered pulmonary artery. Shin'oka T, Imai Y, Ikada Y, N Engl J Med 2001 344 7 532 533 10.1056/NEJM200102153440717 11221621 (Pubitemid 32164912)
43. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H, J Thorac Cardiovasc Surg 2005 129 6 1330 1338 10.1016/j.jtcvs.2004.12.047 15942574 (Pubitemid 40804851)
44. Optimal conduit size for extracardiac Fontan operation. Alexi-Meskishvili V, Ovroutski S, Ewert P, Dahnert I, Berger F, Lange PE, Hetzer R, Eur J Cardiothorac Surg 2000 18 6 690 695 10.1016/S1010-7940(00)00593-5 11113677
45. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Roh JD, Nelson GN, Brennan MP, Mirensky TL, Yi T, Hazlett TF, Tellides G, Sinusas AJ, Pober JS, Saltzman WM, et al. Biomaterials 2008 29 10 1454 1463 10.1016/j.biomaterials.2007.11.041 18164056
46. Development of a model system for preliminary evaluation of tissue-engineered vascular conduits. Goyal A, Wang Y, Su H, Dobrucki LW, Brennan M, Fong P, Dardik A, Tellides G, Sinusas A, Pober JS, et al. J Pediatr Surg 2006 41 4 787 791 10.1016/j.jpedsurg.2006.02.019 16567194
47. Development of a mouse model for evaluation of small diameter vascular grafts. Lopez-Soler RI, Brennan MP, Goyal A, Wang Y, Fong P, Tellides G, Sinusas A, Dardik A, Breuer C, J Surg Res 2007 139 1 1 6 10.1016/j.jss.2006.07.040 17336332 (Pubitemid 46482561)
48. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Roh JD, Sawh-Martinez R, Brennan MP, Jay SM, Devine L, Rao DA, Yi T, Mirensky TL, Nalbandian A, Udelsman B, et al. Proc Natl Acad Sci USA 2010 107 10 4669 4674 10.1073/pnas.0911465107 20207947
49. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Brennan MP, Dardik A, Hibino N, Roh JD, Nelson GN, Papademitris X, Shinoka T, Breuer CK, Ann Surg 2008 248 3 370 377 18791357
50. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H, Circulation 2003 108 14 1729 1734 10.1161/01.CIR.0000092165.32213.61 12963635 (Pubitemid 37243662)
51. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. Hibino N, Villalona G, Pietris N, Duncan DR, Schoffner A, Roh JD, Yi T, Dobrucki LW, Mejias D, Sawh-Martinez R, et al. FASEB J 2011 25 8 2731 9 10.1096/fj.11-182246 21566209